Session » Abstracts: Antiphospholipid Syndrome
- 3:00PM-4:30PM
-
Abstract Number: 0837
Bispecific Autoantigen-T Cell Engagers (BaiTE) to Selectively Target Autoreactive B Cells in Antiphospholipid Syndrome
- 3:00PM-4:30PM
-
Abstract Number: 0841
Clinical and Biologic Predictors of Thrombosis in Persistently Antiphospholipid Antibody Positive Patients: Prospective Analysis of the International APS ACTION Clinical Database and Repository (“Registry”)
- 3:00PM-4:30PM
-
Abstract Number: 0839
Comprehensive Single-cell Analysis Reveals Interferon Pathway Activation and Aberrant B Cell Dynamics in APS Autoimmunity
- 3:00PM-4:30PM
-
Abstract Number: 0842
The Incident Risk and Predictors of Systemic Autoimmune Rheumatic Disease (SARD) Development in Persistently Antiphospholipid Antibody Positive Patients Without SARDs: Prospective Results from the APS ACTION Clinical Database and Repository (“Registry”)
- 3:00PM-4:30PM
-
Abstract Number: 0838
The Mechanistic Impact of IgA anti-beta-2 Glycoprotein I on Accelerated Atherosclerosis in Primary APS
- 3:00PM-4:30PM
-
Abstract Number: 0840
The Platelet Adenosinergic Axis as a Novel Therapeutic Target for Thrombotic APS